Introduction
============

In recent decades, there has been a striking increase of obesity in both developed countries and urban regions of developing countries. Obesity is now a major global public health issue and a further increase of \~50% by 2030 is predicted [@B1], [@B2]. Epidemiological studies have suggested obesity is an important risk factor for colorectal cancer (CRC), with 50-100% increased risks for women and men who have a BMI ≥ 30 [@B3]. Animal studies are in agreement with both diet- and genetically-induced obesity promoting intestinal tumorigenesis [@B4], [@B5]. CRC is a major cause of death: \~50,000 individuals annually in the US and \~700,000 worldwide [@B6], [@B7], thus understanding all of the risk factors for CRC and identifying means to combat them is of the utmost importance.

It is well-known that obesity induces chronic low-grade inflammation in the adipose tissue as well as systemically [@B8], [@B9], and recent animal studies---including our own---indicate that an inflammatory milieu resides in the colon as well [@B10], [@B11]. Our prior study demonstrates that obesity-driven inflammation, exemplified by an increased production of inflammatory cytokine TNF-α, is associated with alterations of several key components (*GSK3β* and *β -catenin*) of the *Wnt*-signaling pathway, [@B10] the over-activation of which is thought to be an early integral step in 90% of human CRCs [@B12], [@B13].

While increasing evidence indicates that obesity-driven chronic intestinal inflammation plays an important role in colorectal tumorigenesis, the origin of this inflammation remains elusive. Recent studies suggest that alterations in the composition and diversity of intestinal microbiome is an important characteristic of obesity [@B14]. Animal studies indicate that both diet- [@B15] and genetically-induced [@B16] obesity alters the composition of microbiome characterized by an expansion of *Firmicutes* and reduction in *Bacteroidetes* at the phylum level. A disruption of the \'normal\' microbial community is thought to increase the risk of pathogen infection and to promote inflammation [@B17].

To understand the role of gut microbiome in linking obesity with inflammation, *Wnt* pathway and tumorigenesis, we sought to examine how high fat diet and obesity *per se* drive gut dysbiosis, promote intestinal inflammation, activate the *Wnt* pathway, and thereby enhance intestinal tumorigenesis using the Apc^+/1638N^ mouse model, the tumorigenic phenotype of which is particularly sensitive to dietary modifications [@B18], [@B19].

Experimental Methods
====================

Animal study
------------

The protocol for this study was approved by the Institutional Animal Care and Use Committee of the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University. A detailed description of the protocol has previously been reported [@B20]. Briefly, in order to study how obesity influences the intestinal microbiome and tumorigenesis, we utilized both high fat diet-induced (60% kcal fat) and genetically-induced (Lepr^db/db^) obese models [@B21]. To study intestinal tumorigenesis, we utilized the Apc^+/1638N^ model [@B22]. Though this model develops tumors predominantly in the small intestine rather than the colorectum, it is the nature of other genetically-engineered rodent models of CRC such as the widely used Apc^Min^ mouse. Nevertheless, the Apc^+/1638N^ model has a mildly tumorigenic phenotype that sensitively responds to dietary modification and the predilection to developing these small intestinal tumors responds to dietary perturbations in the same manner that diet modifies CRC risk in the human, underscoring the relevance of this model to human colonic tumorigenesis [@B18], [@B19]. Since the tumors predominantly occur in the small intestine in this mouse model, the small intestinal microbial constitution is more reflective of the tumor microenvironment, and therefore in this paper we focused on the microbial composition, inflammatory status and expression of *Wnt* pathway-specific genes in the small intestine as opposed to the large intestine.

Three groups with 2 different genotypes and 2 dietary treatments were used in this study: Apc^+/1638N^Lepr^+/+^ fed a low fat diet (10% kcal fat, Apc-LF), Apc^+/1638N^Lepr^+/+^ fed a high fat diet (60% kcal fat, Apc-HF), and Apc^+/1638N^ Lepr^db/db^ fed a low fat diet (Apc-DB). Animals (9-12 mice/group) received diets for 16 weeks from 8 to 24 weeks of age. The compositions of experimental diets were previously described. [@B20] Mice were housed in a controlled environment (inverted 12-h daylight cycle) with *ad libitum* access to food and water.

After 16 weeks on diet, mice were sacrificed, the abdomen was opened, and small intestines were removed onto ice-cold glass plates. Samples of the intestinal contents were harvested, frozen in liquid nitrogen, and stored at -80°C for further microbial abundance analysis. After rinsing thoroughly with ice-cold PBS with protease inhibitors (Roche, Indianapolis, IN), the small intestinal tumors were characterized under a dissecting microscope. The remaining normal-appearing small intestinal mucosa was harvested by gentle scraping with microscope slides at 0^o^C, frozen in liquid nitrogen, and stored at -80 °C for later analysis of inflammatory cytokines and expression of *Wnt* pathway-specific genes.

Quantification of small intestinal microbiome
---------------------------------------------

The relative abundance of 19 bacterial taxa, which have been reported to be associated with the development of colonic adenomas and cancers in mice and/or humans [@B23], were determined by real-time PCR. Most of primers used in this study have been previously validated; the remaining primers were designed on the basis of 16S rDNA gene sequences available from the GenBank database and Ribosomal Database Project database (<http://rdp.cme.msu.edu>/). Primers were synthesized commercially (Invitrogen Life Technologies, Carlsbad, CA), and sequences are listed in Supplementary Data (Table [S1](#SM1){ref-type="supplementary-material"}).

Bacterial DNA was extracted from small intestinal contents using the QIAamp DNA Stool Mini Kit (Qiagen, Valencia, CA) according to the manufacturer\'s instructions. The concentration and purity of extracted DNA was determined using the NanoDrop-2000 spectrophotometer (Thermo Scientific, Waltham, MA). Real-time PCR assays were on the ViiA™ 7 Real-Time PCR System (Applied Biosystems, Foster City, CA). PCR conditions were 15 min at 95°C, followed by 40 cycles of 95°C for 1 min, 30s at the annealing temperature, and then 72°C for 1 min.

Inflammatory cytokine assay
---------------------------

The small intestine mucosa scrapings (50\~100 mg) were mixed with 400 μL lysis buffer (150 mM NaCl, 20 mM Tris, 1 mM EDTA, 1% Triton X-100, pH 7.5) and phosphatase and protease inhibitors (Sigma, St. Louis, MO) were added to inhibit degradation. Samples were homogenized and then centrifuged at 4℃ at 12000 rpm for 30min, the protein fraction was collected, and the total protein concentrations were measured in the extract using the Bradford assay. Concentrations of IL-1β, TNF-α, IL-6 and IFNγ were determined using the Proinflammatory Panel 1 (mouse) V-PLEXTM Kit and QuickPlex SQ 120 (Mesoscale Discovery, Rockville, MD) according to manufacturer\'s protocols. Cytokines are expressed as ng/mg protein.

Gene expression profile
-----------------------

The relative expressions were determined for 6 genes involved in bacterial recognition and inflammatory processes, and 16 genes selected from the *Wnt*pathway cascade including genes of *Wnt*ligands and *Wnt* antagonists, receptors and signaling transduction genes, and the downstream target genes. Briefly, total RNA was extracted from the small intestine with Trizol (Invitrogen, Carlsbad, CA), and cDNA was synthesized with SuperScript III (Invitrogen, Carlsbad, CA, USA). Real-time PCR was performed on the ViiA™ 7 Real-Time PCR System (Applied Biosystems, Foster City, CA). Primer sequences were listed in supplementary Data (*Table [S2](#SM1){ref-type="supplementary-material"}*).

Data analysis
-------------

Data are expressed as means ± SEM. Data analysis was performed using SAS (Version 9.4, SAS Institute, Cary, NC) or GraphPad Prism^TM^ (Version 6, GraphPad Software, La Jolla, CA). Comparisons between groups were made with a T-test or ANOVA and associations were assessed by Pearson\'s Correlation. Significance was accepted when p \< 0.05, and a false discovery rate cutoff of q \< 0.2 was used when multiple comparisons were conducted. Heatmaps were created based on transformed z-score values using HemI software [@B24].

For the bacterial data analysis, the abundance of specific bacterial taxa was normalized to total bacteria (ΔCt = Ct~specific~-Ct~total~), and for the gene expression data analysis, the expression of each gene was normalized to the housekeeping gene GAPDH (Ct~target\ gene~-Ct~GAPDH~). Statistical analyses were performed based on ΔCt. The relative abundance of specific bacterial taxa or relative gene expression in diet- and genetically-induced obese groups (Apc-HF and Apc-DB, respectively) comparing to the control group (Apc-LF) were reported as 2^-ΔΔCt^, where ΔΔCt=ΔCt~Apc-HF~-ΔCt~Apc-LF~ or ΔΔCt=ΔCt~Apc-DB~-ΔCt~Apc-LF~.

Results
=======

Physiological characteristics and intestinal tumors
---------------------------------------------------

Physiological and tumor data have been previously reported [@B20]. Briefly, the lack of leptin receptor in the genetically-induced obese Lepr^db/db^ mouse model (Apc-DB) resulted in significantly increased body weight in both males (64.8%) and females (113%) when compared to the wildtype control animals (Apc-LF) even though both groups were fed a low fat diet (10% kcal fat) (*p* \< 0.01). The high fat diet (60% kcal fat, Apc-HF) also induced significant increases (*p* \< 0.05) in body weight when compared to the low fat diet group (Apc-LF), although the magnitude in both males (44.3%) and females (29.2%) were lower than genetically-induced obesity. Fat mass was also significantly higher in Apc-DB mice compared to Apc-HF and Apc-LF mice, and Apc-HF mice had significantly greater body fat than Apc-LF mice [@B20]. Tumor incidence, the proportion of animals in each group possessing tumors, was 33%, 67% and 100% in Apc-LF, Apc-HF and Apc-DB mice, respectively (p \< 0.01). A similar significant stepwise increase in tumor multiplicity (number of tumors harbored by each animal) and tumor burden (total volume of tumors in each animal) was also observed [@B20].

Small intestinal microbiome in diet- or genetically-induced obese mice
----------------------------------------------------------------------

Among the 19 cancer-related bacterial genera or species studied, the abundance of 4 taxa was altered by diet-induced obesity, while 5 different taxa were altered by genetically-induced obesity (p \< 0.05) (*Fig. [1](#F1){ref-type="fig"}*). Specifically, the genera *Desulfibrio* and *Turicibacter* and species *C.leptum* were reduced while the species *F.prausnitzii* was elevated by high fat intake. The genus *Bifidobacterium*, and the species *A. municiphila* and *E. rectale* were decreased while genus *Peptostreptococcus* and species *E.coli* were increased by genetically-induced obesity. Very interestingly, none of these taxa were significantly altered by both modalities of obesity (*Fig. [2](#F2){ref-type="fig"}*). When a Pearson\'s correlation analysis was performed between the abundance of identified bacterial taxa and the body weight, statistically significant correlations (p \< 0.05) were observed mainly for those bacterial taxa whose abundance was altered by genetically-induced obesity, but not for diet-induced obesity (*Table [1](#T1){ref-type="table"}*).

Transcriptional expression of genes involved in bacterial recognition and pro-inflammatory processes
----------------------------------------------------------------------------------------------------

Among the 6 genes involved in bacterial recognition and pro-inflammatory processes, the transcriptional expression of myeloid differentiation factor 88 (*MyD88*), a cytoplasmic molecule which plays a central role in immune response to many bacterial cell components including lipopolysaccharide, peptidoglycan, and lipopeptide [@B25], [@B26], was significantly elevated in both diet-and genetically-induced obesity groups when comparing to the low fat diet control group (p \< 0.05). In addition, the expression of *NFκB1*, the encoded protein of which plays a central role in determining the specificity of *NFκB* signaling, was significantly higher in the Apc-HF group whereas the expression of *Nod2*, which encodes a protein that recognizes bacterial peptidoglycans and links recognition to the appropriate immune response, was low in the Apc-DB group compared to the Apc-HF group (*Fig. [3](#F3){ref-type="fig"}A*). When a Pearson\'s correlation analysis was performed for those genes involved in bacterial recognition and pro-inflammatory processes including inflammatory cytokines and microbial taxa, we detected a number of correlations among them, and the correlations for the two genera, *Bifidobacterium* and *Turicibacter*, were shown in *Table [2](#T2){ref-type="table"}*.

Intestinal inflammatory cytokine profile
----------------------------------------

Among the 4 inflammatory cytokines examined (IFNγ IL-1β, IL-6 and TNF-α), IFNγ and TNF-α were significantly increased (72% and 60% respectively, p \< 0.05) in the genetically-induced obesity group (Apc-DB) when comparing to the Apc-LF group, whereas IL-6 was significantly increased (58%, p \< 0.05) in the diet-induced obesity group (Apc-HF). Based on the inflammatory cytokine profile (*Fig. [3](#F3){ref-type="fig"}B*), both diet- and genetically-induced obesity resulted in a low-grade inflammation in the small intestine as indicated by numerical or statistically significant elevattions of inflammatory cytokine protein levels. The magnitudes of cytokine elevation for the genetically-induced obesity group were relatively higher than for the diet-induced group.

*Wnt*pathway-specific gene expression profile
---------------------------------------------

We assessed the expression of 16 genes selected from *Wnt* pathway cascade including genes of *Wnt*ligands and *Wnt* antagonists, receptors and signaling transduction genes and the downstream target genes (Fig. *4A*). Among the 16 genes examined, we observed 7 genes whose expressions were significantly elevated (p \< 0.05) by either diet- or genetically-induced obesity or both [Supplementary Materials](#SM1){ref-type="supplementary-material"}, *Table [S2](#SM1){ref-type="supplementary-material"}*). Since the expression patterns between the diet- and genetically-induced groups are not significantly different when compared to the low fat diet control group, we combined the Apc-HF and Apc-DB groups to generate the heatmap. Among the 7 genes identified, three are the *Wnt* pathway downstream target genes, three are receptors and signaling transduction genes, and only 1 gene (*Wnt5A*) is among the *Wnt*ligands and *Wnt*antagonists group (*Fig. [4](#F4){ref-type="fig"}B*).

Pearson\'s correlations of transcriptional expression were then performed between *MyD88*, *NFκB1* and *Nod2*, the 3 genes involved in bacterial recognition and pro-inflammatory processes and, with genes within the *Wnt* pathway cascade. We observed that multiple *Wnt* pathway genes correlated with *MyD88* and *NFκB1* (*Table [3](#T3){ref-type="table"}*), and this was particularly true for downstream target genes and signaling transduction genes. Correlations between *MyD88* and *NFκB1*with *C-Myc* and *Cyclin D1*, the 2 critical *Wnt* pathway downstream oncogenes are shown in *Fig. [4](#F4){ref-type="fig"}C*.

Discussion
==========

Although obesity is an established risk factor for the development of several malignancies ([@B27], [@B28], including CRC [@B29]-[@B31], the detailed mechanisms mediating this relationship require further elucidation. We previously demonstrated that obesity elevates *Wnt*-signaling in the colon [@B10]. By directly comparing two modalities by which obesity is produced the current study expands on prior observations by examining the effects produced by a high fat diet versus those produced by obesity *per se*(i.e.: genetically-induced obesity). Further, the present study also begins to examine the potential roles that members of the intestinal microbiome might play in this process. Findings from this study indicated that diet- and genetically-induced obesity resulted in distinct bacterial patterns, but both of them leads to an elevated state of intestinal inflammation as indicated by increased inflammatory cytokines, and in parallel with that are the alterations of the *Wnt-*signaling pathway and increased tumorigenesis in the obese Apc^+/1638N^ model.

The current study demonstrated that several bacteria are differentially altered by diet- and genetically-induced obesity. Of note, the abundance of genus *Turicibacter was*decreased and species *F. prausnitizii* increased in the small intestine of the Apc-HF, but not the Apc-DB group (*Fig. [2](#F2){ref-type="fig"}*). In line with our observation, Everard*et al*showed that*Turicibacter* decreased markedly in mice fed a high fat diet [@B32]. Data from a couple of studies showing a depletion of T*uricibacter* in animal models of inflammatory bowel disease [@B33], [@B34] raises the question whether this taxa might have anti-inflammatory properties. The species *F. prausnitizii* is generally considered an anti-inflammatory commensal bacterium that can secrete metabolites that block NFκB activation [@B35]. Contrary to our expectations and findings from others [@B36], [@B37], an increased abundance of *F. prausnitizii* was observed in our study. But our data is not unique in this regard: Faval *et al*[@B38] reported that a 24-week intervention with a high saturated fat diet significantly increased *F. prausnitizii* in 88 subjects \'at risk\' of metabolic syndrome. This inconsistency underscores the complexity of intestinal microbiota, and suggests that there may be additional as of yet unidentified factors that interact with *F. prausnitizii* in determining its effects on the intestinal environment.

*A. mucinphila*, *E. rectale* and *Bifidobacterium* decreased whereas *Peptostreptococcus* increased only in the genetically-induced Apc-DB obese group. The mucin-degrading bacterium, *A.muciniphila,*and butyrate-producing bacterium,*E.rectale,*are thought to protect against colorectal cancer and colitis [@B39], [@B40]. Members of the *Bifidobacterium* genus are widely used as probiotics, and its abundance has been shown to be significantly reduced in colon cancer patients [@B41]. *Peptostreptococcus*is a commensal bacterium that can cause a wide variety of infections in multiple sites, including small intestine mucosa. It is also abundant in the gut microbiota of colon cancer patients [@B40]. The changes in these genera and species are therefore all consistent with what one might expect in the Apc-DB group, which displays enhanced tumorigenesis.

Interestingly, when we examined correlations between the altered intestinal microbiota with mouse body weight, the results showed that significant associations were mainly observed for those bacteria altered by genetic-induced obesity (*Table [1](#T1){ref-type="table"}*). This result may simply be due to the fact that a greater magnitude of obesity was achieved with the genetically-induced obesity and therefore correlations might be easier to detect, but might also indicate that the dysbiosis observed in Apc-HF mice might be more determined by aspects of the diet rather than the obese state *per se*.

Despite the differences in microbial profiles between the two modes of obesity, there was a commonality of inflammation. Among the genes involved in bacterial recognition and inflammation, myeloid differentiation factor 88 (MyD88) protein\--a cytoplasmic molecule that plays a central role in the immune response to bacterial cell components, including lipopolysaccharide, peptidoglycan, and lipopeptide [@B25], [@B26]\--was significantly increased in both diet- and genetically-induced obesity (*Fig. [3](#F3){ref-type="fig"}A*). MyD88 has a very complex role in tumorigenesis: its expression has often been observed to have a pro-tumorigenic effect in the liver [@B42] and colorectum [@B43], but it also assumes a tumor suppressive role in some inflammation-associated cancer models [@B44], [@B45]. The findings from these studies reiterate the need for further elucidation of this gene\'s roles in explaining the inter-relationships between the intestinal microbiome, inflammation and tumorigenesis in the setting of obesity. No significant differences were observed in the patterns of elevated inflammatory cytokines between diet- and genetically-induced obesity. The incremental increase in TNF-α protein concentration across the three groups paralleled the incremental increases in both body weight and tumor incidence [@B20] (*Fig. [3](#F3){ref-type="fig"}B*), underscoring prior observations that have established causative links between obesity, intestinal TNF-α, and tumorigenesis [@B4], [@B10].

Similarly, the expression patterns of genes in *Wnt* pathway were not differently altered between the diet- and genetically-induced obese groups when comparing them to the low fat group (*Fig. [4](#F4){ref-type="fig"}B*). When we correlated expressions of those significantly altered genes involved in bacterial recognition and pro-inflammatory processes (*MyD88*, *NFκB1* and *Nod2*) with expressions of genes within the *Wnt* pathway, multiple genes were identified to be significantly associated with *MyD88* and *NFκB1*, particularly the downstream target genes and signaling transduction genes (*Table [3](#T3){ref-type="table"}*). Our prior study [@B10] reported that obesity-promoted inflammation (TNF-α) may phosphorylate GSK3β and thereby activate *Wnt*-signaling and increase expressions of *Wnt* pathway downstream genes. Therefore, it is not surprising a group of downstream target genes whose transcriptions were identified to be elevated in this study. Interestingly, elevated transcriptional levels of a number of signaling transduction genes, such as *Apc*, *GSK3β* and *β-catenin*, were observed in this study. *Apc*, *GSKβ*, and *β-catenin* operate as a complex that plays a critical role in the regulation of *β-catenin* degradation in the *Wnt*pathway [@B46]. However, evidence is limited and inconsistent regarding how a high fat diet or obesity *per se* regulates expression of these genes. For instance, a transcriptional upregulation of *β-catenin* was reported in one study in response to high fat diet [@B47]. whereas another study showed that *β-catenin* protein, but not the mRNA, is elevated in genetic obesity and reduced by calorie restriction [@B48]. Further investigation into the regulation of this complex is needed. Nevertheless, significant correlations between *MyD88* and *NFκB1* with the 2 critical *Wnt*pathway downstream oncogenes, *C-Myc* and *Cyclin D1*, inform the potential mechanism that obesity mediates intestinal tumorigenesis via inflammation-driven activation of *Wnt*-signaling (*Fig. [4](#F4){ref-type="fig"}C*).

This study represented a logical extension of our previous publications [@B10], [@B20] and added significant insights into the mechanisms mediating obesity-associated intestinal cancer. Using the Apc^+/1638N^ mouse model, this study clearly demonstrated that the inflammation-driven *Wnt*-signaling serves as a critical mechanism towards enhanced intestinal cancer in the obese state. In terms of the characterization of microbiome, in this work, we particularly focused on the small intestinal microbial constitution, as opposite the colonic microbial composition, since the tumors exclusively occur in the small intestine in this mouse model and the small intestinal microbiome is more reflective of the tumor microenvironment. We demonstrated several bacterial taxa exclusively associated with the two modalities of obesity, but both leads to similar alterations of genes involved in bacterial recognition (MyD88) and inflammatory cytokines (IFNγ, IL-6 and TNF-α) in parallel with alterations of genes that are integral components of the *Wnt*-signaling cascade in a fashion indicating its activation. In this work, we focused on inflammatory regulation of the critical *Wnt* pathway, alterations of which appear in up to 90% of CRC [@B12], [@B13]. However, it is noteworthy that other pathways may also be altered, probably in a less degree, and thereby contribute to the development of CRC in the obese state. For instance, the MAPK pathway is also a critical pathway in tumorigenesis. The MAPK possesses the capability to phosphate *C-myc*, via which it can interact with the *Wnt* pathway and regulate cell proliferation and apoptosis. A defect of the MAPK pathway has been demonstrated to be able to promote uncontrolled growth, a necessary step for the development of many types of cancers including CRC. The MAPK pathway also plays a critical role in the regulation of a number of the inflammatory regulators, such as NF-κB and AP-1, and in turn leads to tumorigenesis [@B49], [@B50].

In summary, this study has examined how obesity alters the microenvironment of the small intestine of the Apc^+/1638N^mouse. We have demonstrated that, although high fat diet-induced and genetically-induced obesity alter the intestinal microbiome differently, both lead to similar states of biochemical inflammation and similar alterations in gene expression among members of the *Wnt*pathway towards enhancing intestinal tumorigenesis. These salient findings not only demonstrate inflammation-driven *Wnt*-signaling as a novel mechanism mediating obesity-associated intestinal cancer, the information provided by this work also implies that new strategies to suppress inflammation-driven Wnt-signaling can be utilized to attenuate intestinal cancer regardless the two modalities of obesity, but different approaches should be used if targeting to mediate gut microbiome.
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![**Heatmaps of microbiome in the small intestine of mice.** The microbial taxa are ranked based on the relative abundance from the high to the low scale. Microbial taxa with increased abundance appear in the upper boxes (above the white line) and taxa with decreased abundance are in the lower boxes (below the white line). Those taxa whose relative abundance were significantly different in the obese state compared to the lean are listed at the bottom. A) Heatmap for the comparison between the Apc^+/1638N^Lepr^+/+^ fed a high fat diet (60% kcal fat, Apc-HF) and the Apc^+/1638N^Lepr^+/+^ fed a low fat diet (10% kcal fat, Apc-LF). B) Heatmap for the comparison between the Apc^+/1638N^Lepr^db/db^ fed a low fat diet (10% kcal fat, Apc-DB) and the Apc^+/1638N^Lepr^+/+^ fed a low fat diet (10% kcal fat, Apc-LF).](jcav07p1780g001){#F1}

![**Differential influences of high fat- (60% kcal fat, Apc-HF) and genetically-induced (Apc-DB) obesity on the intestinal cancer-related microbiome compared to the low fat control group (10% kcal fat, Apc-LF).** Altered abundances of *Turicibacter*and *F. prausnitzii*are present in high fat diet-induced obesity, and altered abundances for *Bifidobacterium, Peptostreptococcus, A. mucinphila*and *E. rectale*are present in genetically-induced obesity. A) At the genus level. B) At the species level.](jcav07p1780g002){#F2}

![**Impact of obesity on inflammation in the small intestine of mice.** A) Impact of obesity on the expression of genes involved in bacterial recognition and pro-inflammatory processes in the small intestine of mice. B) Impact of obesity on inflammatory cytokines in the small intestine of mice. Apc-LF: Apc^+/1638N^Lepr^+/+^ mice fed a low fat diet (10% kcal fat). Apc-HF: Apc^+/1638N^Lepr^+/+^ mice fed a high fat diet (60% kcal fat) and Apc-DB: Apc^+/1638N^Lepr^db/db^ mice fed a low fat diet (10% kcal fat).](jcav07p1780g003){#F3}

![**Effects of obesity on *Wnt* pathway-specific gene expression.** A) *Wnt*-signaling pathway. 16 genes were selected, including *Wn*ligand*s* and *Wnt* antagonists, receptors, signaling transduction genes and downstream target genes. B) Heatmap for the relative expression of *Wnt* pathway-specific genes examined in the small intestine of mice. The genes are ranked based on the relative expression, from the high to the low. C) Correlations between gene expression of *MyD88* and *NFκB1*, genes involved in bacterial recognition and inflammation, with *C-Myc* and *Cyclin D1*, downstream targets of the *Wnt* pathway. The expression patterns between the diet- and genetically-induced groups are not significantly different when comparing to the low fat diet control group. Therefore, the Apc-HF and Apc-DB groups were combined to generate the heatmap. Apc-LF: Apc^+/1638N^Lepr^+/+^ mice fed a low fat diet (10% kcal fat). Apc-HF: Apc^+/1638N^Lepr^+/+^ mice fed a high fat diet (60% kcal fat, Apc-HF) and Apc-DB: Apc^+/1638N^Lepr^db/db^ mice fed a low fat diet (10% kcal fat).](jcav07p1780g004){#F4}

###### 

Correlations between the abundance of bacteria and body weight.

  Bacteria             Relative Coefficience (R)   Bacteria           Relative Coefficience (R)
  -------------------- --------------------------- ------------------ ---------------------------
  *Bifidobacterium*    -0.408 \*                   *A.muciniphila*    -0.390 \*
  *Desulfovibrio*      -0.165                      *C.leptum*         -0.021
  *Pepstreptococcus*   0.428 \*                    *E.rectale*        -0.435 \*
  *Turicibacter*       0.104                       *E.coli*           0.439 \*
                                                   *F.prausnitizii*   -0.225

\* Indicates a significant correlation (*p* \< 0.05). Negative coefficient values indicate a reverse correlation, whereas positive coefficient values indicate a positive correlation. The correlation analyses were performed on all experimental animals.

###### 

The correlation of transcriptional expression between genes involved in bacterial recognition and pro-inflammatory process with the abundance of microbial taxa.

  ----------------------------------------------------------------------------------------------
                            Bifidobacterium        Turicibacter           
  ------------------------- ---------------------- ---------------------- ----------------------
  Genes involved in\        Nod2                   r= 0.61 (p = 0.044)    NS
  bacterial Recognition                                                   

  MyD-88                    NS                     r= -0.56 (p = 0.020)   

  Genes involved in pro-\   NF-κB1                 NS                     r= -0.61 (p = 0.007)
  inflammation                                                            

  TNF-α                     r= -0.69 (p = 0.013)   NS                     
  ----------------------------------------------------------------------------------------------

###### 

Correlations of expression between genes involved in bacterial recognition and inflammation with genes integral to the *Wnt* pathway cascade.

  Genes involved in bacterial recognition & pro-inflammatory process   Genes within Wnt Pathway Cascade                                                                 
  -------------------------------------------------------------------- ---------------------------------- ------------------------------------------------------------- ---------------------------------------------------------
  MyD88                                                                NS                                 LRP6\*, Apc\*\*, GSK3β\*\*, β-catenin\*\*, Akt\*\*            C-myc\*\*, Cyclin D1\*, Jnk1\*\*, C-Jun\*
  NFκB1                                                                SFRP5\*                            Dvl\*, LRP6\*\*, Apc\*\*, GSK3β\*\*, β-catenin\*\*, Akt\*\*   C-myc\*\*, Cyclin D1\*\*, Axin 2\*, Jnk1\*\*, C-Jun\*\*
  Nod2                                                                 NS                                 NS                                                            NS

\* *p* \< 0.05; \*\* *p*\< 0.01; NS: No statistically significant correlations identified.
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